Skip to main content
Monika Metzger, MD
Monika Metzger, MD

Monika Metzger, MD

Member, St. Jude Faculty

  • Director, Central and South America Region, St. Jude Global




MD – Rheinisch-Westfaelisch Technische Hochschule (RWTH), Aachen, Germany
Dr Med – Rheinisch-Westfaelisch Technische Hochschule (RWTH), Aachen, Germany
MA – Rheinisch-Westfaelisch Technische Hochschule (RWTH), Aachen, Germany
MSc – University of Tennessee at Memphis, College of Health Sciences, Memphis, Tennessee

Clinical Interests

  • Frontline therapy of Hodgkin lymphoma in different resource settings
  • Frontline therapy of Burkitt lymphoma in Central America
  • Global Pediatric Medicine
  • Staging Evaluation and Response Harmonization for Childhood, Adolescent and Young Adult Hodgkin Lymphoma

Selected Publications

Santiago T, Hayes C, Polanco AC, (…), Metzger ML*. Improving Immunohistochemistry Capability for Pediatric Cancer Care in the Central American and Caribbean Region: A Report From the AHOPCA Pathology Working Group.  Journal of Global Oncology 4, 1-9, 2018.

Flerlage JE, Metzger ML, Bhakta N. The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice? Blood [Epub ahead of print] 2018.

Kluge R, Kurch L, Georgi T, Metzger M*. Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma. Semin Nucl Med 47(3):242-257, 2017.

Denburg A, Cuadrado C, Alexis C, (…), Metzger M, et al. Improving childhood cancer care in Latin America and the Caribbean: a PAHO Childhood Cancer Working Group position statement. Lancet Oncol 18(6):709-711, 2017.

Flerlage JE, Kelly KM, Beishuizen A, (…), Metzger ML*. Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement. Pediatr Blood Cancer 64 (7): e26421, 2017.

Gonzalez-Ramella O, Freigeiro D, Castellanos ME, (…), Metzger ML*. Joining forces for children with cancer in Latin America. Lancet Oncol 17(6):701-3, 2016.

Hines MR, Mulrooney DA, Hudson MM, (…), Metzger ML*. Pregnancy-associated cardiomyopathy in survivors of childhood cancer. J Cancer Surviv 10(1):113-21, 2016.

Green DM, Zhu L, Wang M, (…), Metzger M, et al. Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE). Ann Am Thorac Soc 13(9):1575-85, 2

Bhakta N, Liu Q, Yeo F, Baassiri M, (…), Metzger ML, et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 17(9):1325-34, 2016.

Mauz-Körholz C*, Metzger ML*, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Körholz D. Pediatric Hodgkin Lymphoma. J Clin Oncol 33(27):2975-85, 2015.

Bhojwani D, McCarville MB, Choi JK, Sawyer J, Metzger ML, et al. The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Br J Haematol 168(6):845-53, 2015.

Bhojwani D, Darbandi R, Pei D, (…) Metzger ML*. Severe hypertriglyceridemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer 50(15):2685-94, 2014.

Mulrooney DA, Nunnery SE, (…), Metzger ML, et al. Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma. Cancer 120(22):3536-44, 2014.

Castellanos EM, Barrantes JC, Báez LF, (…), Metzger ML, de Alarcón PA. A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999. Pediatr Blood Cancer 61(6):997-1002, 2014.

Sandlund JT, Pui CH, Zhou Y, Onciu M, Campana D, Hudson MM, Inaba H, Metzger ML, et al. Results of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children's Research Hospital from 1962 to 2002. Ann Oncol 24(9):2425-9, 2013.

Friedmann AM, Wolfson JA, Hudson MM, (…), Metzger ML*. Relapse after treatment of pediatric Hodgkin Lymphoma: Outcome and role of surveillance after end of therapy. Pediatr Blood Cancer 60(9):1458-63, 2013.

Metzger ML*, Billett A, Link MP. The impact of drug shortages on children with cancer--the example of mechlorethamine.  N Engl J Med 367(26):2461-3, 2012.

Metzger ML*, Weinstein HJ, Hudson, MM, et al. Association between radiotherapy vs no radiotherpay based on early response to VAMP chemotherapy and survival among children with favorable risk Hodgkin lymphoma. JAMA 307(24):2609-16, 2012.

Sandlund, JT, Pui, CH, Mahmoud, (…), Metzger, ML, et al. Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma. Ann Oncol 22(2):468-71, 2011.

Metzger, ML*, Hudson, MM, Krasin, MJ, et al.  Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients. Cancer 116(18):4376-84, 2010.

Hines-Thomas MR, Howard SC, Hudson MM, (…), Metzger ML*. Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin lymphoma.  Haematologica 95(10):1691-6, 2010.

Metzger ML*, Hudson MM. Balancing efficacy and safety in the treatment of adolescents with Hodgkin's lymphoma. J Clin Oncol 20;27(36):6071-3, 2009.

Shulkin BL, Goodin GA, McCarville MB, (...), Metzger ML*. Bone and FDG PET/CT scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leuk Lymphoma 50(11):1794-1802, 2009.

Hines-Thomas M, Kaste SC, Hudson MM, (…), Metzger ML*. Comparison of gallium and PET scans in diagnosis and follow-up of pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 51(2):198-203, 2008.

Metzger ML*, Castellino SM, Hudson MM, et al. Effect of race on the outcome of pediatric patients with Hodgkin lymphoma. J Clin Oncol 26(8):1282-8, 2008.

Bashir H, Hudson MM, Kaste SC, (…), Metzger ML*. Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients. Pediatr Blood Cancer 49(5):666-71, 2007.

Metzger ML*, Hudson MM, Somes GW et al. White race as a risk factor for hypothyroidism following treatment for pediatric Hodgkin lymphoma. J Clin Oncol 24(10):1516-21, 2006. 

Metzger ML*, Howard SC, Hudson MM, et al. Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr Blood Cancer 46(3):314-9, 2006. 

Krasin MJ, Rai SN, Kun LE, Merchant TE, Metzger ML, et al. Patterns of treatment failure in pediatric and young adult patients with Hodgkin’s disease: Local disease control with combined modality therapy. J Clin Oncol 23:8406-8413, 2005. 

Metzger ML*, Howard SC, Fu LC, et al.  Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet  362:706-708, 2003.

Last update: December 2018